Novartis Ag (NVSEF) Enterprise Value Growth (3y) (2012 - 2026)

Novartis Ag (NVSEF) Enterprise Value Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2026	55.98%
Dec 31, 2025	50.29%
Sep 30, 2025	37.88%
Jun 30, 2025	24.28%
Mar 31, 2025	-31.74%
Dec 31, 2024	26.09%
Sep 30, 2024	12.29%
Jun 30, 2024	-687.43%
Mar 31, 2024	-12.76%
Dec 31, 2023	-9.31%
Sep 30, 2023	39.32%
Jun 30, 2023	-547.86%
Mar 31, 2023	40.06%
Dec 31, 2022	-18.36%
Sep 30, 2022	29.58%
Jun 30, 2022	-28.27%
Mar 31, 2022	30.57%
Dec 31, 2021	-22.61%
Sep 30, 2021	-7.21%
Jun 30, 2021	26.02%